Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    15322749 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
Conditions: Impaired Glucose Tolerance;   Cardiovascular Disease;   Glucose Metabolism Disorders
Interventions: Drug: Ramipril;   Drug: Rosiglitazone

Study has passed its completion date and status has not been verified in more than two years.